Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Study Design and Outcomes of Korean Obstructive Lung Disease (KOLD) Cohort Study

  • Park, Tai Sun (Department of Pulmonary and Critical Care Medicine and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Jae Seung (Department of Pulmonary and Critical Care Medicine and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Seo, Joon Beom (Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Hong, Yoonki (Department of Internal Medicine, Kangwon National University College of Medicine) ;
  • Yoo, Jung-Wan (Department of Pulmonary and Critical Care Medicine and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kang, Byung Ju (Department of Pulmonary and Critical Care Medicine and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Sei Won (Department of Pulmonary and Critical Care Medicine and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Oh, Yeon-Mok (Department of Pulmonary and Critical Care Medicine and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Sang-Do (Department of Pulmonary and Critical Care Medicine and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2013.10.11
  • Accepted : 2014.03.11
  • Published : 2014.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The Korean Obstructive Lung Disease (KOLD) Cohort Study is a prospective longitudinal study of patients with chronic obstructive pulmonary disease (COPD), asthma, or other unclassified obstructive lung diseases. It was designed to develop new classification models and biomarkers that predict clinically relevant outcomes for patients with obstructive lung diseases. Methods: Patients over 18 years old who have chronic respiratory symptoms and airflow limitations or bronchial hyper-responsiveness were enrolled at 17 centers in South Korea. After a baseline visit, the subjects were followed up every 3 months for various assessments. Results: From June 2005 to October 2013, a total of 477 subjects (433 [91%] males; 381 [80%] diagnosed with COPD) were enrolled. Analyses of the KOLD Cohort Study identified distinct phenotypes in patients with COPD, and predictors of therapeutic responses and exacerbations as well as the factors related to pulmonary hypertension in COPD. In addition, several genotypes were associated with radiological phenotypes and therapeutic responses among Korean COPD patients. Conclusion: The KOLD Cohort Study is one of the leading long-term prospective longitudinal studies investigating heterogeneity of the COPD and is expected to provide new insights for pathogenesis and the long-term progression of COPD.

Keywords

References

  1. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006;27:397-412. https://doi.org/10.1183/09031936.06.00025805
  2. Liu S, Zhou Y, Wang X, Wang D, Lu J, Zheng J, et al. Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China. Thorax 2007;62:889-97. https://doi.org/10.1136/thx.2006.061457
  3. Yoo KH, Kim YS, Sheen SS, Park JH, Hwang YI, Kim SH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology 2011;16:659-65. https://doi.org/10.1111/j.1440-1843.2011.01951.x
  4. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010;182:598-604. https://doi.org/10.1164/rccm.200912-1843CC
  5. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010;11:122. https://doi.org/10.1186/1465-9921-11-122
  6. Kim V, Han MK, Vance GB, Make BJ, Newell JD, Hokanson JE, et al. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest 2011;140:626-33. https://doi.org/10.1378/chest.10-2948
  7. Nishimura M, Makita H, Nagai K, Konno S, Nasuhara Y, Hasegawa M, et al. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;185:44-52. https://doi.org/10.1164/rccm.201106-0992OC
  8. Lee JH, Lee YK, Kim EK, Kim TH, Huh JW, Kim WJ, et al. Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype. Respir Med 2010;104:542-9. https://doi.org/10.1016/j.rmed.2009.10.024
  9. Lee JS, Huh JW, Chae EJ, Seo JB, Ra SW, Lee JH, et al. Predictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary disease. J Korean Med Sci 2011;26:379-85. https://doi.org/10.3346/jkms.2011.26.3.379
  10. Lee JS, Huh JW, Chae EJ, Seo JB, Ra SW, Lee JH, et al. Different therapeutic responses in chronic obstructive pulmonary disease subgroups. Int J Tuberc Lung Dis 2011;15:1104-10. https://doi.org/10.5588/ijtld.10.0553
  11. Lee JS, Huh JW, Chae EJ, Seo JB, Ra SW, Lee JH, et al. Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease. Clin Physiol Funct Imaging 2012;32:12-8. https://doi.org/10.1111/j.1475-097X.2011.01046.x
  12. Kim WJ, Oh YM, Sung J, Kim TH, Huh JW, Jung H, et al. Lung function response to 12-week treatment with combined inhalation of long-acting beta2 agonist and glucocorticoid according to ADRB2 polymorphism in patients with chronic obstructive pulmonary disease. Lung 2008;186:381-6. https://doi.org/10.1007/s00408-008-9103-9
  13. Kim WJ, Sheen SS, Kim TH, Huh JW, Lee JH, Kim EK, et al. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD. Respirology 2009;14:260-3. https://doi.org/10.1111/j.1440-1843.2008.01425.x
  14. Yoo JW, Hong Y, Seo JB, Chae EJ, Ra SW, Lee JH, et al. Comparison of clinico-physiologic and CT imaging risk factors for COPD exacerbation. J Korean Med Sci 2011;26:1606-12. https://doi.org/10.3346/jkms.2011.26.12.1606
  15. Lee YK, Oh YM, Lee JH, Kim EK, Lee JH, Kim N, et al. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung 2008;186:157-65. https://doi.org/10.1007/s00408-008-9071-0
  16. Chae EJ, Seo JB, Song JW, Kim N, Park BW, Lee YK, et al. Slope of emphysema index: an objective descriptor of regional heterogeneity of emphysema and an independent determinant of pulmonary function. AJR Am J Roentgenol 2010;194:W248-55. https://doi.org/10.2214/AJR.09.2672
  17. Kim WJ, Oh YM, Sung J, Lee YK, Seo JB, Kim N, et al. CT scanning- based phenotypes vary with ADRB2 polymorphisms in chronic obstructive pulmonary disease. Respir Med 2009;103:98-103. https://doi.org/10.1016/j.rmed.2008.07.025
  18. Jo KW, Ra SW, Chae EJ, Seo JB, Kim NK, Lee JH, et al. Three phenotypes of obstructive lung disease in the elderly. Int J Tuberc Lung Dis 2010;14:1481-8.
  19. Lee JH, Oh YM, Seo JB, Lee YK, Kim WJ, Sheen SS, et al. Pulmonary artery pressure in chronic obstructive pulmonary disease without resting hypoxaemia. Int J Tuberc Lung Dis 2011;15:830-7. https://doi.org/10.5588/ijtld.10.0598
  20. Kim TB, Oh YM, Chang YS, Cho YS, Jang AS, Cho SH, et al. The reality of an intermediate type between asthma and COPD in practice. Respir Care 2012;57:1248-53. https://doi.org/10.4187/respcare.01232
  21. Fletcher C, Peto R, Tinker C, Speizer FE. The natural history of chronic bronchitis and emphysema: an eight-year study of early chronic obstructive lung disease in working men in London. New York: Oxford University Press; 1976.
  22. Rennard SI, Vestbo J. Natural histories of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:878-83. https://doi.org/10.1513/pats.200804-035QC
  23. Foreman MG, Zhang L, Murphy J, Hansel NN, Make B, Hokanson JE, et al. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med 2011;184:414-20. https://doi.org/10.1164/rccm.201011-1928OC
  24. Kirkpatrick d P, Dransfield MT. Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment. Curr Opin Pulm Med 2009;15:100-4. https://doi.org/10.1097/MCP.0b013e3283232825
  25. Dransfield MT, Bailey WC. COPD: racial disparities in susceptibility, treatment, and outcomes. Clin Chest Med 2006;27:463-71. https://doi.org/10.1016/j.ccm.2006.04.005
  26. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009;374:733-43. https://doi.org/10.1016/S0140-6736(09)61303-9
  27. Brutsche MH, Downs SH, Schindler C, Gerbase MW, Schwartz J, Frey M, et al. Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA cohort study. Thorax 2006;61:671-7. https://doi.org/10.1136/thx.2005.052241
  28. de Marco R, Accordini S, Marcon A, Cerveri I, Anto JM, Gislason T, et al. Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. Am J Respir Crit Care Med 2011;183:891-7. https://doi.org/10.1164/rccm.201007-1125OC
  29. Han MK, Bartholmai B, Liu LX, Murray S, Curtis JL, Sciurba FC, et al. Clinical significance of radiologic characterizations in COPD. COPD 2009;6:459-67. https://doi.org/10.3109/15412550903341513
  30. ANOLD, Asian Network for Obstructive Lung Disease [Internet]. Seoul: ANOLD Coordination center; [cited 2013 Oct 11]. Available from: http://www.anold.org/.

Cited by

  1. Detailed analysis of the density change on chest CT of COPD using non-rigid registration of inspiration/expiration CT scans vol.25, pp.2, 2014, https://doi.org/10.1007/s00330-014-3418-0
  2. Association of plasma adipokines with chronic obstructive pulmonary disease severity and progression. vol.12, pp.7, 2014, https://doi.org/10.1513/annalsats.201501-005oc
  3. Optimal threshold of subtraction method for quantification of air-trapping on coregistered CT in COPD patients vol.26, pp.7, 2014, https://doi.org/10.1007/s00330-015-4070-z
  4. Graphic analysis of flow-volume curves: a pilot study vol.16, pp.None, 2016, https://doi.org/10.1186/s12890-016-0182-8
  5. Size variation and collapse of emphysema holes at inspiration and expiration CT scan: evaluation with modified length scale method and image co-registration vol.12, pp.None, 2017, https://doi.org/10.2147/copd.s130081
  6. Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort vol.19, pp.None, 2018, https://doi.org/10.1186/s12931-018-0737-8
  7. Serial blood eosinophils and clinical outcome in patients with chronic obstructive pulmonary disease vol.19, pp.None, 2014, https://doi.org/10.1186/s12931-018-0840-x
  8. Clinical impacts of the classification by 2017 GOLD guideline comparing previous ones on outcomes of COPD in real-world cohorts vol.13, pp.None, 2014, https://doi.org/10.2147/copd.s177238
  9. Incidence of Adverse Effects and Discontinuation Rate between Patients Receiving 250 Micrograms and 500 Micrograms of Roflumilast: A Comparative Study vol.81, pp.4, 2014, https://doi.org/10.4046/trd.2018.0015
  10. Resting hyperinflation and emphysema on the clinical course of COPD vol.9, pp.None, 2019, https://doi.org/10.1038/s41598-019-40411-1
  11. Low morphometric complexity of emphysematous lesions predicts survival in chronic obstructive pulmonary disease patients vol.29, pp.1, 2014, https://doi.org/10.1007/s00330-018-5551-7
  12. Outcome of Regular Inhaled Treatment in GOLD A Chronic Obstructive Pulmonary Disease Patients vol.98, pp.4, 2014, https://doi.org/10.1159/000495756
  13. Risk of acute exacerbations in chronic obstructive pulmonary disease associated with biomass smoke compared with tobacco smoke vol.19, pp.None, 2014, https://doi.org/10.1186/s12890-019-0833-7
  14. Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts vol.20, pp.None, 2014, https://doi.org/10.1186/s12931-019-1029-7
  15. Impact of Body Mass Index Change on the Prognosis of Chronic Obstructive Pulmonary Disease vol.99, pp.11, 2014, https://doi.org/10.1159/000511022
  16. KMBARC registry: protocol for a multicentre observational cohort study on non-cystic fibrosis bronchiectasis in Korea vol.10, pp.1, 2014, https://doi.org/10.1136/bmjopen-2019-034090
  17. Relative Regional Air Volume Change Maps at the Acinar Scale Reflect Variable Ventilation in Low Lung Attenuation of COPD patients vol.27, pp.11, 2014, https://doi.org/10.1016/j.acra.2019.12.004
  18. Low serum lymphocyte level is associated with poor exercise capacity and quality of life in chronic obstructive pulmonary disease vol.10, pp.None, 2014, https://doi.org/10.1038/s41598-020-68670-3
  19. Deep radiomics-based survival prediction in patients with chronic obstructive pulmonary disease vol.11, pp.1, 2014, https://doi.org/10.1038/s41598-021-94535-4
  20. A comparative study of chest CT findings regarding the effects of regional dust exposure on patients with COPD living in urban areas and rural areas near cement plants vol.22, pp.1, 2021, https://doi.org/10.1186/s12931-021-01649-4